FRI-329-Comparison of seladelpar and combinations with liraglutide or selonsertib for improvement of fibrosis and NASH in a diet-induced and biopsy-confirmed mouse model of NASH — Yun‐Jung Choi (2019) | RDL Network
FRI-329-Comparison of seladelpar and combinations with liraglutide or selonsertib for improvement of fibrosis and NASH in a diet-induced and biopsy-confirmed mouse model of NASH
Hannah K. Drescher, Ralf Weiskirchen, Annabelle Fülöp, Carsten Hopf, Estíbaliz González de San Román, Pitter F. Huesgen, Alain de Bruin, Laura Bongiovanni, Annette Christ, René H. Tolba, Christian Trautwein, Daniela C. Kroy
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.